On April 21st, CF PHARMTECH (02652) spent HK$299,700 to repurchase 13,500 shares.
Changfeng Pharmaceutical (02652) announced that on April 21, 2026, the company repurchased 13,500 shares at a cost of 299,700 Hong Kong dollars, at a repurchase price of 22.18-22.34 Hong Kong dollars per share.
CF PHARMTECH (02652) announced that on April 21, 2026, the company spent HK$299,700 to buy back 13,500 shares at a repurchase price of HK$22.18-22.34 per share.
Related Articles

AI HEALTH TECH (01715) recommends terminating the current share purchase plan and adopting a new share purchase plan.

VC HOLDINGS (00821): Li Chen resigns as executive director.

Preview of US Stock Market | The three major stock index futures rose together, and tonight the market will face three tests: retail data, Trump, and Powell.
AI HEALTH TECH (01715) recommends terminating the current share purchase plan and adopting a new share purchase plan.

VC HOLDINGS (00821): Li Chen resigns as executive director.

Preview of US Stock Market | The three major stock index futures rose together, and tonight the market will face three tests: retail data, Trump, and Powell.

RECOMMEND

Hong Kong Hard‑Tech Companies Enhance Canton Fair Presence As Veterans And Newcomers Expand International Networks
17/04/2026

Thousand‑Fold Oversubscription In Hong Kong IPOs Signals Multiple Market Shifts
17/04/2026

Rising Compute Costs Drive Industry Price Increases As Institutions Expect Internet Firms To Outperform In Q1
17/04/2026


